基本信息
浏览量:3
职业迁徙
个人简介
Research Synopsis
Biomarkers for tumor response and normal tissue toxicity in liver cancer SBRT
Principal Investigator of a Randomized Phase III Study of Sorafenib versus Stereotactic Body Radiation Therapy followed by Sorafenib in Hepatocellular Carcinoma
Principal Investigator of a Randomized Phase III Study of Whole Liver Radiation Therapy versus Best Supportive Care for Patients with Painful Liver Cancer
Biomarkers for tumor response and normal tissue toxicity in liver cancer SBRT
Principal Investigator of a Randomized Phase III Study of Sorafenib versus Stereotactic Body Radiation Therapy followed by Sorafenib in Hepatocellular Carcinoma
Principal Investigator of a Randomized Phase III Study of Whole Liver Radiation Therapy versus Best Supportive Care for Patients with Painful Liver Cancer
研究兴趣
论文共 436 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2024): 100740-100740
Sara Beltran Ponce,Yevgeniya Gokun, Francisca Douglass,Laura Dawson,Eric Miller, Charles R. Thomas Jr,Kenneth Pitter,Lanla Conteh,Dayssy A. Diaz
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTEno. 2 (2024): 264-274
Robert Olson, Hadassah Abraham, Curtis Leclerc,Alexander Benny,Sarah Baker,Quinn Matthews,Nick Chng,Alanah Bergman,Benjamin Mou,Emma M. Dunne,Devin Schellenberg,Will Jiang,
BMC Cancerno. 1 (2024): 1-14
Laura Ann Dawson,Jolie Ringash,Alysa Fairchild, Paul Stos, Kristopher Dennis,Aamer Mahmud,Teri Lynn Stuckless, Francois Vincent, David Roberge, Matthew Follwell,Raimond Wong,Derek Jonker,
crossref(2024)
RADIOTHERAPY AND ONCOLOGY (2024): 110118-110118
PRACTICAL RADIATION ONCOLOGYno. 2 (2024): 134-145
RADIOTHERAPY AND ONCOLOGY (2023): S68-S68
RADIOTHERAPY AND ONCOLOGY (2023): S33-S33
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology (2023): 109588-109588
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn